Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Osteoporoses”

613 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 613 results

Large-scale testing (Phase 3)UnknownNCT05305183
What this trial is testing

A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis
Shandong New Time Pharmaceutical Co., LTD 330
Not applicableStudy completedNCT04063813
What this trial is testing

Parameters of Exercise to Prevent Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
University of Michigan 40
Testing effectiveness (Phase 2)Study completedNCT00238745
What this trial is testing

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Who this might be right for
Postmenopausal Osteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer 375
Post-approval studies (Phase 4)Study completedNCT04026256
What this trial is testing

Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration

Who this might be right for
Postmenopausal Osteoporosis
Massachusetts General Hospital 37
Large-scale testing (Phase 3)Study completedNCT00919711
What this trial is testing

Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy

Who this might be right for
Osteoporosis
Amgen 870
Not applicableStudy completedNCT03091088
What this trial is testing

Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis, OsteopeniaPhysical Activity
University of Valencia 36
Not applicableStudy completedNCT00361595
What this trial is testing

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

Who this might be right for
Osteoporosis
The Cleveland Clinic 35
Testing effectiveness (Phase 2)Study completedNCT00887965
What this trial is testing

A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

Who this might be right for
Low Bone MassLow Bone Mineral DensityOsteoporosis+1 more
Amgen 15
Not applicableStudy completedNCT04836637
What this trial is testing

ValoRization of Dairy Sidestreams to Fight Calcium dEficits iN Postmenopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
University of Copenhagen 420
Early research (Phase 1)Study completedNCT00676312
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects

Who this might be right for
Postmenopausal Osteoporosis
Novartis 32
Early research (Phase 1)Study completedNCT04798313
What this trial is testing

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adults

Who this might be right for
Osteoporosis, Postmenopausal
Mabwell (Shanghai) Bioscience Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT00369850
What this trial is testing

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

Who this might be right for
Breast CancerOsteoporosis
ETOP IBCSG Partners Foundation 458
Large-scale testing (Phase 3)Study completedNCT03974100
What this trial is testing

Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Women With Osteoporosis
Sandoz 527
Not applicableStudy completedNCT02304757
What this trial is testing

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Who this might be right for
Differentiated Thyroid CancerOsteoporosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 142
Large-scale testing (Phase 3)Study completedNCT07028320
What this trial is testing

To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk

Who this might be right for
Postmenopausal Women With Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd. 493
Not applicableStudy completedNCT05332626
What this trial is testing

Lactobacillus Acidophilus and Postmenopausal Women

Who this might be right for
Bone LossPost Menopausal OsteoporosisMineralization
Poznan University of Life Sciences 90
Not applicableActive Not RecruitingNCT02822378
What this trial is testing

Dried Plums and Bone Health in Postmenopausal Women

Who this might be right for
Postmenopausal Osteoporosis
Penn State University 322
Not applicableStudy completedNCT00515593
What this trial is testing

PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

Who this might be right for
PostmenopauseOsteoporosis
Nycomed 110
Testing effectiveness (Phase 2)Study completedNCT00918749
What this trial is testing

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

Who this might be right for
Postmenopausal Osteoporosis
Warner Chilcott 205
Testing effectiveness (Phase 2)Study completedNCT01992159
What this trial is testing

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis (PMO)
Amgen 252
Next Page